八菱科技(002592.SZ)子公司擬斥500萬元在海口設立全資子公司
格隆匯10月18日丨八菱科技(002592.SZ)公佈,公司於2019年7月23日披露了《關於控股子公司簽訂框架合作協議的公告》,公司控股子公司北京弘潤天源基因生物技術有限公司(“弘潤天源”)與北京安傑瑪化粧品有限公司、海南省海口市人民政府簽訂了《框架合作協議》,鑑於海南獨特的地理區位、政策、生態等優勢,弘潤天源與安傑瑪計劃在海口註冊設立項目公司,建設集健康服務、醫療養護、休閒保健等核心產業及產品於一體的生命健康產業園。
基於上述弘潤天源與海口市政府簽訂的戰略合作協議,為便於弘潤天源在海南業務的發展,弘潤天源擬以自有資金在海口投資設立全資子公司海南弘潤天源基因生物技術有限公司,註冊資本人民幣500萬元。
海南弘潤天源基因生物技術有限公司經營範圍:生物技術推廣服務,生物工程技術開發、技術諮詢、技術交流、技術轉讓、技術推廣、技術服務,生物質能技術服務,生物質能資源數據庫信息系統平台,健康諮詢,批發礦產品、建材及化工產品,零售第一類醫療器械,零售第二類醫療器械,道路貨物運輸,技術推廣服務,貨物運輸代理,醫學研究和試驗發展,零售食品、飲料及煙草製品。(一般經營項目自主經營,許可經營項目憑相關許可或批准文件經營)(依法須經批准的項目,經相關部門批准後方可開展經營活動。)
弘潤天源此次對外投資設立全資子公司是基於未來戰略發展規劃,目的在於進一步拓展弘潤天源的業務領域,加快弘潤天源的產業佈局,優化弘潤天源的產業結構,滿足弘潤天源未來發展需要。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.